Eli Lilly breaks ground on $3.5B Pennsylvania manufacturing site for obesity meds

Seeking Alpha · November 12, 2026, 22:18 UTC

Tickers: $LLY

Topics: Capital Expenditure Manufacturing Expansion Obesity Drugs

Read the full article at Seeking Alpha

Part of the story Major US Indices Post Weekly Gains Despite Friday Market Retreat (2 articles)

More World news

KeyCorp Announces Redemption of Series E Preferred Stock PR Newswire · November 13, 2026, 21:27 UTC
FDA Approves AstraZeneca's Imfinzi in Combination with Padcev for Bladder Cancer Seeking Alpha · November 13, 2026, 21:23 UTC
American Strategic Investment Reports Q3 Revenue Decline and Negative GAAP EPS Seeking Alpha · November 13, 2026, 21:24 UTC
Travel Sector Outlook: Marriott and Booking Holdings Face Divergent Holiday Forecasts Motley Fool · November 13, 2026, 21:21 UTC
Nvidia vs. AMD: Comparing Growth and Leadership Stability Motley Fool · November 13, 2026, 21:23 UTC
Bragg Gaming Group Reports Q3 2026 Revenue Decline Amid Strategic Shift and Restructuring Motley Fool · November 13, 2026, 21:23 UTC
Prairie Operating Co. Outlines 2026 Production Targets and Capital Expenditure Guidance Seeking Alpha · November 13, 2026, 21:20 UTC
PenFed Credit Union Announces Fan Activation at Texas A&M Blackout Game PR Newswire · November 13, 2026, 21:22 UTC
Micromem Technologies Announces C$250,000 Private Placement Offering Seeking Alpha · November 13, 2026, 21:18 UTC
FAA Issues Nationwide Ground Stop at All U.S. Airports Due to Safety Concerns Seeking Alpha · November 13, 2026, 21:13 UTC